These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Law PK; Bertorini TE; Goodwin TG; Chen M; Fang QW; Li HJ; Kirby DS; Florendo JA; Herrod HG; Golden GS Lancet; 1990 Jul; 336(8707):114-5. PubMed ID: 1697393 [No Abstract] [Full Text] [Related]
44. The muscular dystrophies. Dubowitz V Postgrad Med J; 1992 Jul; 68(801):500-6. PubMed ID: 1437944 [No Abstract] [Full Text] [Related]
45. Interventions for muscular dystrophy: molecular medicines entering the clinic. Bushby K; Lochmüller H; Lynn S; Straub V Lancet; 2009 Nov; 374(9704):1849-56. PubMed ID: 19944865 [TBL] [Abstract][Full Text] [Related]
46. Myoblast transfer in muscular dystrophy: panacea or pie in the sky? Dubowitz V Neuromuscul Disord; 1992; 2(5-6):305-10. PubMed ID: 1300179 [No Abstract] [Full Text] [Related]
48. Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy. Neumeyer AM; Cros D; McKenna-Yasek D; Zawadzka A; Hoffman EP; Pegoraro E; Hunter RG; Munsat TL; Brown RH Neurology; 1998 Aug; 51(2):589-92. PubMed ID: 9710042 [TBL] [Abstract][Full Text] [Related]
49. The principles and practice of myoblast transfer. Karpati G Adv Exp Med Biol; 1990; 280():69-74. PubMed ID: 2248156 [No Abstract] [Full Text] [Related]
50. [Duchenne muscular dystrophy: clinical analysis and prospects of genetic therapy]. Mateos F Rev Neurol; 1995; 23 Suppl 3():S404-7. PubMed ID: 7497322 [No Abstract] [Full Text] [Related]
51. Muscular dystrophy--reason for optimism? Burton EA; Davies KE Cell; 2002 Jan; 108(1):5-8. PubMed ID: 11792315 [TBL] [Abstract][Full Text] [Related]
52. Myoblast transplantation in inherited myopathies. Morgan JE; Watt DJ Mol Cell Biol Hum Dis Ser; 1993; 3():303-31. PubMed ID: 8111544 [No Abstract] [Full Text] [Related]
53. VII International Congress on neuromuscular diseases, Munich, September 16-22, 1990. Kakulas BA; Byrne E Brain Pathol; 1991 Jan; 1(2):135-6. PubMed ID: 1688298 [No Abstract] [Full Text] [Related]
54. First human myoblast transfer therapy continues to show dystrophin after 6 years. Law PK; Goodwin TG; Fang Q; Hall TL; Quinley T; Vastagh G; Duggirala V; Larkin C; Florendo JA; Li L; Jackson T; Yoo TJ; Chase N; Neel M; Krahn T; Holcomb R Cell Transplant; 1997; 6(1):95-100. PubMed ID: 9040960 [No Abstract] [Full Text] [Related]
55. [Reflexions apropos of recent progresses in molecular genetics of myopathies]. Kaplan JC Arch Pediatr; 1995 Aug; 2(8):715-8. PubMed ID: 7550833 [No Abstract] [Full Text] [Related]
56. Transplantation of skeletal muscle into a host with muscular dystrophy. Laird JL; Timmer RF Tex Rep Biol Med; 1966; 24(2):169-79. PubMed ID: 5962240 [No Abstract] [Full Text] [Related]
57. [Therapeutic strategies for muscular dystrophy: F based on the international guideline]. Matsuo M; Nonaka I No To Hattatsu; 2014 Mar; 46(2):87-8. PubMed ID: 24738181 [No Abstract] [Full Text] [Related]